Reliq Health Technologies, Inc. Expands into Pediatric Remote Monitoring, Expects to Add 3,000 New Pediatric Patients in TX by Q2 2024
September 07 2023 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, is pleased to
announce that it has expanded its services to include remote
monitoring for pediatric patients with diabetes and other eligible
conditions. The Company expects to add over 3,000 pediatric
patients in Texas to its iUGO Care platform by Q2 2024 through its
existing contracts with home health agencies in the State.
“We are very excited to be expanding our
services to include pediatric patients,” said Dr. Lisa Crossley,
CEO of Reliq Health Technologies, Inc. “In Texas, Medicaid covers
Home Telemonitoring (remote patient monitoring) for children with
diabetes, hypertension, end-stage solid organ disease, organ
transplant or who require mechanical ventilation. These vulnerable
young patients can benefit greatly from in-home monitoring of their
chronic conditions to identify potential complications, enable
early interventions and prevent hospitalizations. Pediatric
patients in particular have better health outcomes and report
better quality of life when they are able to receive care in the
home, surrounded by family and friends. Providing proactive support
to pediatric patients through in-home monitoring can have a
dramatic impact on patients’ long-term health, helping to prevent
nerve damage, cardiovascular disease, organ damage and other
complications that can lead to shortened lifespans and poor quality
of life in adulthood. We expect to add over 3,000 pediatric
patients to our iUGO Care platform by Q2 2024 through our existing
contracts with home health agencies in the State, at an average
revenue of $50 per patient per month at ~70% gross margin.
Onboarding will begin next month.”
Reliq Health
Reliq Health Technologies is a rapidly growing
global healthcare technology company that specializes in developing
innovative Virtual Care solutions for the multi-billion dollar
Healthcare market. Reliq’s powerful iUGO Care platform supports
care coordination and community-based virtual healthcare. iUGO Care
allows complex patients to receive high quality care at home,
improving health outcomes, enhancing quality of life for patients
and families and reducing the cost of care delivery. iUGO Care
provides real-time access to remote patient monitoring data,
allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:
A2AJTB.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information please contact:
Company ContactInvestor Relations
at ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Jul 2023 to Jul 2024